The increase in phospho-Akt level in breast tumor samples correlates with poor prognosis (Stal et al. 2003; Tokunaga et al. 2006; Zhou et al. 2004) and predicts a worse outcome among endocrine-treated patients (Perez-Tenorio, 2002). Here, AKT1 is linked to breast neoplasm.